SeaCrest Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

SeaCrest Wealth Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-653	Closed	-$53K	–	1155
2019 Q1	$53K	Hold	653	–	–	0.01%	916
2018 Q4	$35K	Sell	653 -1,459	-69%	-$74.4K	0.01%	1022
2018 Q3	$109K	Buy	2,112 +46	+2%	+$2.16K	0.02%	716
2018 Q2	$86K	Buy	2,066 +148	+8%	+$6.56K	0.02%	777
2018 Q1	$85K	Buy	1,918 +248	+15%	+$12.6K	0.02%	759
2017 Q4	$84K	Buy	+1,670	New	+$91.6K	0.02%	784

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SeaCrest Wealth Management's IONS Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2019, closing a stake of 653 shares — an estimated $53K sold.

SeaCrest Wealth Management first reported a position in IONS in Q4 2017 and held it in 6 quarters. The position peaked at $109K in Q3 2018. 396 funds tracked by Wall St. Rank hold IONS as of Q2 2019.

SeaCrest Wealth Management reported no remaining Ionis Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 653 Ionis Pharmaceuticals shares in Q2 2019, an estimated $53K.
SeaCrest Wealth Management first reported a position in Ionis Pharmaceuticals in Q4 2017 and held it in 6 quarters.
SeaCrest Wealth Management's Ionis Pharmaceuticals position peaked at $109K in Q3 2018.
396 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.